Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Free Cash Flow (2016 - 2025)

STRATA Skin Sciences' Free Cash Flow history spans 14 years, with the latest figure at -$1.1 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 197.25% year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$3.5 million, down 76.13%, while the annual FY2024 figure was -$1.4 million, 73.85% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$1.1 million at STRATA Skin Sciences, up from -$1.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $974000.0 in Q2 2021 and bottomed at -$2.6 million in Q1 2023.
  • The 5-year median for Free Cash Flow is -$887000.0 (2022), against an average of -$921157.9.
  • The largest annual shift saw Free Cash Flow surged 157.35% in 2024 before it crashed 864.23% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$461000.0 in 2021, then plummeted by 229.72% to -$1.5 million in 2022, then soared by 77.17% to -$347000.0 in 2023, then soared by 157.35% to $199000.0 in 2024, then plummeted by 643.72% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Free Cash Flow are -$1.1 million (Q3 2025), -$1.9 million (Q2 2025), and -$749000.0 (Q1 2025).